MICHAEL PLATT: Open Payments
NPI 1588801500 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,180 in 90 payments from 16 companies in 2025. Trend: 2023 $1,043 · 2024 $4,618 · 2025 $4,180
Food & beverage: $4,069Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $717 |
| E.R. Squibb & Sons, L.L.C. | 15 | $540 |
| Alkermes, Inc. | 12 | $448 |
| Corium, LLC | 4 | $417 |
| Axsome Therapeutics, Inc. | 8 | $364 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $310 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $289 |
| ABBVIE INC. | 10 | $254 |
| Janssen Scientific Affairs, LLC | 3 | $245 |
| Teva Pharmaceuticals USA, Inc. | 6 | $237 |
Products named: INGREZZA, COBENFY, ARISTADA, Azstarys, CAPLYTA, VRAYLAR, SPRAVATO, Auvelity.
Industry payments across IN — which companies pay providers there.
